» Articles » PMID: 34114199

Comparison of Two Different Surgical Strategies for Breast Cancer Patients Treated with Mastectomy Plus Sentinel Lymph Node Biopsy

Overview
Journal Updates Surg
Specialty General Surgery
Date 2021 Jun 11
PMID 34114199
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Two separated incisions are generally adopted in breast cancer patients treated by mastectomy plus sentinel lymph node biopsy (SLNB). However, one-incision procedure is also applied in clinical practice. The outcomes of the two different surgical strategies remain unknown. This issue needs to be investigated. The medical records of breast cancer patients who underwent a mastectomy combined with an SLNB were reviewed retrospectively. Group A comprised patients who received a single incision for both the mastectomy and SLNB. Group B comprised patients who received a second incision for the SLNB. Demographics and outcomes were compared between the two groups. There were 280 female patients divided into Groups A (n = 130) and B (n = 150) included in this study. Preoperatively, the two groups were similar in demographics for age, tumor size, tumor location, body mass index, pathologic type, and cancer stage (P > 0.05). Group A showed shorter surgical times (129.5 ± 29.0 vs. 136.7 ± 21.9 min), less postoperative upper limb numbness (12.3% vs. 25.3%), and more harvested sentinel lymph nodes (3.2 ± 1.1 vs. 2.7 ± 1.0) than Group B (P < 0.05). There were no significant differences for intraoperative blood loss, total postoperative drainage amount, hospital stay, upper limb motility, upper limb pain, upper limb edema, number of metastatic sentinel lymph nodes, follow-up time, or recurrent cases (P > 0.05). The one-incision approach for a breast cancer mastectomy plus SLNB has several advantages over the two-incision approach, including a shorter surgical time, decreased upper limb numbness, and the harvesting of more sentinel lymph nodes. Further prospective randomized controlled clinical trials should be designed to verify the current findings.

Citing Articles

Mean platelet volume may not decrease in patients with acute appendicitis.

Beyan C, Beyan E Updates Surg. 2021; 74(3):1169-1170.

PMID: 33528798 DOI: 10.1007/s13304-021-00988-7.

References
1.
Zhou Y, Li Y, Mao F, Zhang J, Zhu Q, Shen S . Preliminary study of contrast-enhanced ultrasound in combination with blue dye vs. indocyanine green fluorescence, in combination with blue dye for sentinel lymph node biopsy in breast cancer. BMC Cancer. 2019; 19(1):939. PMC: 6787996. DOI: 10.1186/s12885-019-6165-4. View

2.
Giuliano A, McCall L, Beitsch P, Whitworth P, Blumencranz P, Leitch A . Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010; 252(3):426-32. PMC: 5593421. DOI: 10.1097/SLA.0b013e3181f08f32. View

3.
Donker M, van Tienhoven G, Straver M, Meijnen P, van de Velde C, Mansel R . Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014; 15(12):1303-10. PMC: 4291166. DOI: 10.1016/S1470-2045(14)70460-7. View

4.
Morrow M, Khan A . Locoregional Management After Neoadjuvant Chemotherapy. J Clin Oncol. 2020; 38(20):2281-2289. PMC: 7343435. DOI: 10.1200/JCO.19.02576. View

5.
Yuan L, Qi X, Zhang Y, Yang X, Zhang F, Fan L . Comparison of sentinel lymph node detection performances using blue dye in conjunction with indocyanine green or radioisotope in breast cancer patients: a prospective single-center randomized study. Cancer Biol Med. 2019; 15(4):452-460. PMC: 6372915. DOI: 10.20892/j.issn.2095-3941.2018.0270. View